Emergency Use Authorization
Emergency use authorization allows vaccines to be distributed during a pandemic without full FDA approval, prioritizing known benefits over potential risks. While trials for adults included substantial participants, pediatric trials have raised questions about the necessity and safety of vaccines for children, especially given the low risk of severe COVID-19 in this demographic. Concerns about myocarditis following vaccination further complicate the risk-benefit analysis for younger populations.In this clip
From this podcast
Dhru Purohit Show
#229: Should Kids Get a COVID-19 Vaccine? with Pediatrician Dr. Elisa Song
Related Questions